37 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease in HIV-AIDS ... encephalitis • Mycobacterium ... • Disseminated Mycobacterium ... HIVAIDS #IDSA #management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease in HIV-AIDS ... encephalitis • Mycobacterium ... • Disseminated Mycobacterium ... HIVAIDS #IDSA #management
Prophylaxis Against Opportunistic Infections in Persons with Human Immunodeficiency Virus Infection
#Pharm #Management #CD4Count #AIDS #HIV #Prophylaxis
Prophylaxis Against ... Opportunistic Infections ... #Pharm #Management ... CD4Count #AIDS #HIV ... Opportunistic #Infections
Post-Exposure Prophylaxis (PEP) - CDC Guidelines

BIDMC Infectious Diseases Fellowship @BIDMC_IDFellows

#PostExposure #Prophylaxis #PEP #CDC #Guidelines #management #pharmacology
Post-Exposure Prophylaxis ... BIDMC Infectious ... BIDMC_IDFellows #PostExposure ... #CDC #Guidelines ... #management #pharmacology
Post-Exposure Prophylaxis (PEP) Monitoring
 • Initial / ED Visit: HIV Ab/Ag, Hep B serologies, HCV Ab,
Post-Exposure Prophylaxis ... Ab - BIDMC Infectious ... BIDMC_IDFellows #PostExposure ... #Prophylaxis #PEP ... laboratory #timeline #hiv
Prophylaxis to Prevent First Episode of Selected Opportunistic Infections
#Pharm #Management #CD4Count #AIDS #HIV #Prophylaxis #Prophylactic #Antibiotics
Prophylaxis to Prevent ... Opportunistic Infections ... #Pharm #Management ... CD4Count #AIDS #HIV ... Opportunistic #Infections
Genital Herpes Simplex - CDC 2021 Treatment Guidelines
Recommended Regimens:
 • First clinical episode of genital herpes
2021 Treatment Guidelines ... in persons with HIV ... with HIV infection ... CDC2021 #Treatment #Guidelines ... #Management #STI
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Active TB: • HIV ... are pulmonary • HIV ... TST or IGRA HIV ... : • HIV-infected ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Active TB: • HIV ... are pulmonary • HIV ... TST or IGRA HIV ... : • HIV-infected ... TB #Diagnosis #Management
Asplenia Management
 • Key Pathogens: H. influenzae type b, Neisseria meningitidis, Capnocytophaga spp, Malaria, Babesia
 •
Asplenia Management ... PCV13, PPSV 23, Hib ... • Antibiotic Prophylaxis ... Fever or systemic infection ... #prophylaxis